Pathfinder Cell Therapy
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Pathfinder Cell Therapy generated cash of -$963,000, which is more than the previous year. Cash used in financing activities reached the amount of $945,000 last year. Net change in cash is therefore -$18,000.
Cash Flow
| 2012 | -2.02M | 0 | 1.83M |
|---|---|---|---|
| 2013 | -1.60M | 0 | 1.63M |
| 2014 | -963K | 0 | 945K |
PFND Cash Flow Statement (2012 – 2014)
| 2014 | 2013 | 2012 | |
|---|---|---|---|
Cash at beginning of period | 44K | 9K | 196K |
Operating activities | |||
Net income | -1.39M | -1.70M | -2.15M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 3K | 11K | 20K |
Stock-based compensation expense | 2K | 5K | 12K |
| Deferred income tax benefit | 2K | 5K | 12K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 28K | 26K |
Inventories | 0 | 33K | 18K |
Accounts payable | 39K | 114K | -167K |
Cash generated by operating activities | -963K | -1.60M | -2.02M |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 |
Financing activities | |||
Common Stock Issued | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | -60K | -99K | -128K |
Cash used in financing activities | 945K | 1.63M | 1.83M |
Net Change In Cash | -18K | 35K | -187K |
Cash at end of period | 26K | 44K | 9K |